Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
Gurubasavaraja Swamy Purawarga Matada(Drug Discovery Laboratory (Norway)), Sapna Vyas Bhargava(University of Kota), Nahid Abbas(Rajiv Gandhi University of Health Sciences), Abhishek Ghara(Unknown), Arka Das(Rajiv Gandhi University of Health Sciences), Ekta Singh(Rajiv Gandhi University of Health Sciences), Prasad Sanjay Dhiwar(Mahatma Gandhi Mission Institute of Health Sciences)
Cited by 37
Related Papers
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
|Medicinal Chemistry Research|2021|35
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
|European Journal of Medicinal Chemistry|2024|32
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
|Journal of Biomolecular Structure and Dynamics|2023|28
An updated literature on BRAF inhibitors (2018–2023)
|Molecular Diversity|2023|24
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review
|Inflammopharmacology|2021|21